Maziyar Panahi

Varun Singh, Lucas Krauss, Sami Jaghouar et al.

We present the technical report for Arcee Trinity Large, a sparse Mixture-of-Experts model with 400B total parameters and 13B activated per token. Additionally, we report on Trinity Nano and Trinity Mini, with Trinity Nano having 6B total parameters with 1B activated per token, Trinity Mini having 26B total parameters with 3B activated per token. The models' modern architecture includes interleaved local and global attention, gated attention, depth-scaled sandwich norm, and sigmoid routing for Mixture-of-Experts. For Trinity Large, we also introduce a new MoE load balancing strategy titled Soft-clamped Momentum Expert Bias Updates (SMEBU). We train the models using the Muon optimizer. All three models completed training with zero loss spikes. Trinity Nano and Trinity Mini were pre-trained on 10 trillion tokens, and Trinity Large was pre-trained on 17 trillion tokens. The model checkpoints are available at https://huggingface.co/arcee-ai.

Maziyar Panahi

Named-entity recognition (NER) is fundamental to extracting structured information from the >80% of healthcare data that resides in unstructured clinical notes and biomedical literature. Despite recent advances with large language models, achieving state-of-the-art performance across diverse entity types while maintaining computational efficiency remains a significant challenge. We introduce OpenMed NER, a suite of open-source, domain-adapted transformer models that combine lightweight domain-adaptive pre-training (DAPT) with parameter-efficient Low-Rank Adaptation (LoRA). Our approach performs cost-effective DAPT on a 350k-passage corpus compiled from ethically sourced, publicly available research repositories and de-identified clinical notes (PubMed, arXiv, and MIMIC-III) using DeBERTa-v3, PubMedBERT, and BioELECTRA backbones. This is followed by task-specific fine-tuning with LoRA, which updates less than 1.5% of model parameters. We evaluate our models on 12 established biomedical NER benchmarks spanning chemicals, diseases, genes, and species. OpenMed NER achieves new state-of-the-art micro-F1 scores on 10 of these 12 datasets, with substantial gains across diverse entity types. Our models advance the state-of-the-art on foundational disease and chemical benchmarks (e.g., BC5CDR-Disease, +2.70 pp), while delivering even larger improvements of over 5.3 and 9.7 percentage points on more specialized gene and clinical cell line corpora. This work demonstrates that strategically adapted open-source models can surpass closed-source solutions. This performance is achieved with remarkable efficiency: training completes in under 12 hours on a single GPU with a low carbon footprint (< 1.2 kg CO2e), producing permissively licensed, open-source checkpoints designed to help practitioners facilitate compliance with emerging data protection and AI regulations, such as the EU AI Act.